Most Recent Articles by Anna Olechowska
Treatment with brexpiprazole as adjunctive antidepressant therapy was safe and effective in patients with major depressive disorder.
In pediatric patients with bipolar I depression, long-term treatment with lurasidone 20 mg/day is effective in reducing depressive symptoms.
In pediatric patients with ADHD, treatment with dasotraline 4 mg/day was effective in treating a range of ADHD-related symptoms and behaviors.
Younger patients treated with antipsychotics after experiencing a first episode of psychosis are at an increased risk for metabolic syndrome and cardiovascular disease.
Longitudinal associations between diabetes and cognitive decline have been reported.
More Articles by Anna Olechowska
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- FOSTA-SESTA Threatens Sex Worker Livelihoods: What Mental Health Providers Should Know
- Strong Social Networks May Mitigate the Effects of Childhood Adversity
- Sodium Valproate May Lower Amygdala Volume in Pediatric Bipolar Disorder
- False Positives in Mood Disorders Questionnaire Screening for Bipolar Disorder
- Suicidal Behavior More Likely in Depression, Bipolar Disorder With Mixed Features
- Medical Clearance of Psych Patients in the ED: Consensus Recommendations
- From Abused Child to Serial Killer: Investigating Nature vs Nurture in Methods of Murder
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Dialectical Behavior Therapy Effective in Reducing Suicide Attempts, Self-Harm in Adolescents
- Novel Parent-Child Interaction Therapy Targets Preschool-Aged Depression
- Brain Activation Predicts Quetiapine Response in Adolescent Bipolar Depression
- Challenges Psychiatrists Face in Treating Patients with Bipolar Disorder
- Parent-Child Interaction Therapy May Improve Depression and Emotional Function
- Identifying Problems of Functioning in Schizophrenia Informs Approaches to Intervention
- Visual Hallucinations in Dementia and Parkinson Disease: Assessment of Patient Experiences